TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | 2 | 16 | 2 | -28 | 8 | -0 |
| S | %wins | 67 | 67 | 33 | 33 | 100 | 67 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/09 16:37 | 7/2/09 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hage Raymond Joseph | MD | O | SVP. Com | S.dm | -484 | 2.88 | 17 | -168 | -97 | 5 | D | -6 | 27 | 52 | 256 | 59 | -1 | 20 | 15 | -6 | -7 | 60 | 30 | -5 | -23 |
9/22/08 14:29 | 9/18/08 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hage Raymond Joseph | PA | O | SVP,Comm | S.m | -92 | 3.05 | 1 | -30 | -29 | 74 | D | -14 | -15 | 23 | 19 | 22 | 14 | 9 | 7 | -4 | 0 | -32 | -30 | -75 | 58 |
8/29/07 15:45 | 8/27/07 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hage Raymond Joseph | MD | O | SVP,Comm | S | -33 | 3.16 | 2 | -11 | -9 | 104 | D | 148 | -22 | -9 | 3 | 1 | -2 | 2 | 0 | 6 | 13 | 20 | 5 | -4 | -11 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |